 1. Subjects who completed their assigned study drug treatment in the previous study NCT01705145 and elected not to enroll in the ivacaftor arm and subjects who prematurely discontinued treatment in the previous study and received at least 1 dose of study drug treatment in the previous study will be eligible for enrollment in the observational arm. 